The Challenge of Change - Managing Excipients Control
Colorcon
09-Feb-2012 - OptiNose has received US FDA approval to start Phase III trials of its nasal delivery device.
09-Feb-2012 - Eli Lilly has licensed a spray-dried dispersion (SDD) technology from Bend Research, expanding its manufacturing capabilities.
09-Feb-2012 - AMPAC Fine Chemicals posted a 50 per cent jump in revenues after the return of sales from its antiviral business.
08-Feb-2012 - AMRI posted a Q4 loss on lower sales but predicts that contracting revenues and margins will increase in 2012 thanks to cost cutting measures and new contracts
08-Feb-2012 - Pharma supply chain consortium Rx-360 has advised drugmakers to check their L-Arginine stocks, warning that a recent surge in demand could limit supplies.
08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
08-Feb-2012 - GSK is developing tablets it can compress without excipients to cut the time taken to reach the clinic by up to nine months.
07-Feb-2012 - Shanghai Pharmaceuticals has bought a 70 per cent stake in ingredients developer and manufacturer Changzhou Kony Pharm in a bid to boost its standing in the API market.
07-Feb-2012 - Australia is considering steps to stop chemicals used in drug manufacturing from being diverted by terrorists to make explosives.
06-Feb-2012 - Johnson Matthey says sales of an anti-addiction API were the key to gains made by its fine chemicals business in Q3.
06-Feb-2012 - A US drug shortages act aims to make drug production more efficient by quickening review of post-approval manufacturing changes.
02-Feb-2012 - A round-up of news in the contract manufacturing space, with developments at Foster Delivery Sciences, Excella, Catalent and RohnerChem.
02-Feb-2012 - European Commission plans to add three APIs to its list of water polluting chemicals could result in costs to pharmaceutical companies.
01-Feb-2012 - Food ingredients and flavours firm Kerry Group is to build a cell culture and media development lab for the pharmaceutical biomanufacuturing sector.
01-Feb-2012 - The resignation of CEO Axel Muller was a mutual decision and not linked to delayed efforts to win European approval for the asthma drug Flutiform says delivery tech firm SkyePharma.
01-Feb-2012 - Drugmaker Watson Pharmaceuticals has broke grounds on an R&D lab in New Jersey, US.
01-Feb-2012 - Encap Drug Delivery has won a contract manufacturing deal for a European licensed liquid-filled capsule product after the owner parted from its current CMO.
31-Jan-2012 - DSM Pharmaceutical Products (DPP) will sell APIs made by Indian manufacturer Indoco Remedies in a new agreement that fits with its global expansion plan.
31-Jan-2012 - Ingredient maker Dishman Pharmaceuticals has confirmed that it may offload its Chinese API (active pharmaceutical ingredients) factory.
30-Jan-2012 - BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound at less than cost to manufacturers in Europe.
30-Jan-2012 - Patheon will focus its upcoming growth efforts on solubility enhancing tech after receiving an influx of requests from clients.
26-Jan-2012 - Europe is considering forcing API manufacturers to verify the source of starting materials as part of GMP revisions.
25-Jan-2012 - in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.
25-Jan-2012 - Ibuprofen API maker Albemarle says favourable volumes and pricing helped drive gains made by fine chemicals unit in Q4.
25-Jan-2012 - Ashland is investing in production assets and raising prices as it looks to get the most from its $3.2bn acquisition.